Is Adeshwar Meditex overvalued or undervalued?

As of 22 August 2025, Adeshwar Meditex has moved from a fair to an attractive valuation grade. The company appears to be undervalued, particularly when considering its key financial ratios such as a PE ratio of 12.20, an EV to EBITDA of 8.69, and a Price to Book Value of 0.72. These metrics suggest that the company is trading at a discount compared to its peers.
In comparison to its industry peers, Adeshwar Meditex's valuation stands out as more favorable. For instance, Poly Medicure has a PE ratio of 58.35 and an EV to EBITDA of 43.56, while Blue Jet Health shows a PE of 37.46 and an EV to EBITDA of 28.93, both categorized as very expensive. Despite recent underperformance relative to the Sensex, with a year-to-date return of -32.69% compared to the Sensex's 4.05%, the current valuation indicates potential for recovery and growth in the future.